← Open Payments lookup

F. OMAR TORDILLA: Open Payments

NPI 1225063795 · ESCONDIDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$355 in 19 payments from 8 companies in 2025. Trend: 2023 $128 · 2024 $117 · 2025 $355

Food & beverage: $355
CompanyPaymentsAmount
Novo Nordisk Inc5$111
GlaxoSmithKline, LLC.3$57
Otsuka America Pharmaceutical, Inc.3$53
Lilly USA, LLC3$48
PFIZER INC.2$32
Gilead Sciences, Inc.1$28
Sumitomo Pharma America, Inc.1$16
BioWound Solutions, Inc.1$10

Products named: Rybelsus, REXULTI, Ozempic, SHINGRIX, MOUNJARO, PAXLOVID, GEMTESA, TRELEGY ELLIPTA.

Industry payments across CA — which companies pay providers there.